Protein Mapping Study Reveals Valuable Clues for COVID-19 Drug Development

National Institutes of Health (NIH) sent this bulletin at 10/27/2020 09:34 AM EDT

Posted on October 27th, 2020 by Dr. Francis Collins

Protein Mapping Study Reveals Valuable Clues for COVID-19 Drug Development

One way to fight COVID-19 is with drugs that directly target SARS-CoV-2, the novel coronavirus that causes the disease. That’s the strategy employed by remdesivir, the only antiviral drug currently authorized by the U.S. Food and Drug Administration to treat COVID-19. Another promising strategy is drugs that target the proteins...

Follow Dr. Collins on Twitter

Get posts via RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIH…Turning Discovery Into Health^®